Photo by pawel_czerwinski from unsplash
Subepidermal bullous disorders (SEBD) are a heterogeneous group of vesiculobullous diseases because of antibody‐mediated destruction of proteins of the dermo‐epidermal junction. Direct immunofluorescence (DIF) is the gold standard for diagnosis.… Click to show full abstract
Subepidermal bullous disorders (SEBD) are a heterogeneous group of vesiculobullous diseases because of antibody‐mediated destruction of proteins of the dermo‐epidermal junction. Direct immunofluorescence (DIF) is the gold standard for diagnosis. BIOCHIP‐indirect immunofluorescence (IIF) is a novel serological test that combines multiple target antigens in a single field. The present study aimed to evaluate the utility of the pattern‐based approach in BIOCHIP‐IIF for the diagnosis of SEBD.
Journal Title: Journal of Cutaneous Pathology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!